CCR10 and pulmonary fibrosis: These results demonstrate that KB004-directed targeting of CCR10+ IPF cells in humanized NSG mice was less efficacious therapeutically compared with its effects preventatively, possibly due to the loss of immune effector cells with time in this NSG mouse model of lung fibrosis.